• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Possible prediction to fluorouracil (5-FU) anti-cancer agent -Studies of urinary pyrimidine levels in the cancer patients and 5-FU pharmacokinetics in the patients with cancer.

Research Project

Project/Area Number 10672154
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 応用薬理学・医療系薬学
Research InstitutionJichi Medical School

Principal Investigator

TOKUE Akihiko (2000)  Faculty of Medicine, Jichi Medical School, Professor, 医学部, 教授 (80049022)

原田 和博 (1998-1999)  自治医科大学, 医学部, 講師 (70245059)

Co-Investigator(Kenkyū-buntansha) KOBAYASHI Eiji  Faculty of Medicine, Jichi Medical School, Associate Professor, 医学部, 助教授 (00245044)
FUJIMURA Akio  Faculty of Medicine, Jichi Medical School, Professor, 医学部, 教授 (90156901)
徳江 章彦  自治医科大学, 医学部, 教授 (80049022)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 2000: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1999: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1998: ¥1,100,000 (Direct Cost: ¥1,100,000)
Keywords5-fluorouracil / urinary uracil / urinary dihydrouracil / pharmacokinetics / reference range / dihydropyrimidine dehydrogenase
Research Abstract

Insufficiency of dihydropyrimidine dehydrogenase or dihydropyrimidinase, enzymes that catalyze the breakdown of pyrimidine chemotherapy agents such as 5-fluorouracil, may cause serious adverse reactions to these agents. We attempted to establish the reference range for urinary pyrimidines in the 10 cancer patients (8 gastric cancer, and 2 renal carcinoma) to detect individuals with abnormal pyrimidine metabolism. Urinary dihydrouracil and uracil levels were determined by high-performance liquid chromatography with column switching. The concentrations of 5-FU were significantly different among each patients (T max ; 5 to 10 min, C max ; 102.9 to 1121 ng/ml, and AUC ; 1820 to 11381 ng/ml.min). Especially, in the patients with gastric cancer, 5-FU concentrations was markedly increased from prioperative to postoperative stage. To evaluate the influence of gastrectomy on absorption, the changes in blood levels of 5-FU preparations before after gastrectomy were comparatively studied in the rat. The greatest influence was given to 5-FU dry syrup ; to the peak level in blood was shortened after operation, and the distributed amount to blood was about 10 times that before operation.

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • Research Products

    (11 results)

All Other

All Publications (11 results)

  • [Publications] Kobayashi M, et al.: "Effects of dosing time and schedule on cisplatin-induced nephrotoxicity in rats."J.Pharm.Pharmacol. 52. 1233-1237 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hosoya Y, et al: "Combination effects of tamoxifen plus 5-fluorouracil on gastric cancer cell lines in vitro."Cancer Letters. 140. 139-143 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Arakawa M, et al: "Determination the Concentration 5-Fluorouracil and its Metabolites Plasma by HPLC"TDM. XV:2. 149-150 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Harada K, et al: "Influence of gastrectomy on the plasma level of orally administrated 5-fluorouracil - A study on patients with gastric cancer-"RECENT, ADVANCES IN CLINICAL PHARMACOLOGY. 20. 118-119 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hosoya Y, et al.: "Combination effects of tamoxifen plus 5-fluorouracil on gastric cancer cell lines in vitro."Cancer Letters. 140. 139-143 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hosoya Y.et al.: "Effects o Dosing Time and Schedule on Cisplation-Induced Nephrotoxicity in Rats."J pharm Pharmaco. 52. 1233-1237 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Arakawa M, et al.: "Determination the Concentration 5-Fluorouracil and its Metabolites Plasma by HPLC"TDM. XV : 2. 149-150 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Harada K, et al.: "Influence of gastrectomy on the plasma level of orally administrated 5-fluorouracil -A study on patients with gastric cancer-"RECENT ADVANCES IN CLINICAL ARMACOLOGY20. 20. 118-119 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kobayashi M, et al.: "Effects of dosing time and schedule on cisplatin-induced nephrotoxicity in rats."J.Pharm.Pharmacol. 52. 1233-1237 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 小林英司: "時間薬理学の治療への応用"臨床薬理. 30(6). 805-809 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 原田和博、他: "胃切除の血中5-FU濃度に及ぼす影響-胃癌患者を対象とした研究-"臨床薬理の進歩'99. 118-122 (1999)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi